Hikma offers a full range of Glimepiride treatment for patients with type 2 Diabetes Mellitus with the registration of the new strengths Glorion 6mg and its innovative strength Glorion 8mg. Hikma markets Glorion in 7 countries in MENA region (Jordan, Saudi Arabia, Lebanon, Libya, Algeria, Yemen and Iraq).